PURPOSE: Previous evaluation of our institutional experience with stage IV breast cancer patients with an intact primary tumor (IPT) did not reveal an overall survival (OS) benefit for surgery at 32.1 months median follow-up. We assessed the impact of surgery after 74.2 months median follow-up, and the effect of systemic therapy and local radiotherapy (RT). METHODS: We reviewed the records of all patients presenting from 1997 to 2002 with stage IV disease with an IPT. Cox proportional hazards modeling was used to assess differences in survival between treatment groups. RESULTS: Seventy-four (35.6 %) of 208 patients underwent resection of the IPT. After adjustment for covariates, surgery was associated with improved OS (p = 0.04). Multivariable analysis revealed that estrogen receptor (ER) positivity (p = 0.002) and having only a single focus of metastatic disease (p = 0.05) were also associated with improved OS. Surgery was highly associated with receipt of RT (p = 0.0003). RT was significantly associated with improved survival (p = 0.015) in an exploratory analysis. CONCLUSIONS: Stage IV breast cancer patients with an IPT treated surgically had significantly improved OS. Radiation to the primary was also associated with improved survival, but this was evident only with adjustment for the effect of surgery. These findings may be limited by selection bias. Completion of ongoing prospective randomized trials is needed to conclusively determine whether stage IV patients with an IPT should be offered aggressive locoregional therapy.
PURPOSE: Previous evaluation of our institutional experience with stage IV breast cancerpatients with an intact primary tumor (IPT) did not reveal an overall survival (OS) benefit for surgery at 32.1 months median follow-up. We assessed the impact of surgery after 74.2 months median follow-up, and the effect of systemic therapy and local radiotherapy (RT). METHODS: We reviewed the records of all patients presenting from 1997 to 2002 with stage IV disease with an IPT. Cox proportional hazards modeling was used to assess differences in survival between treatment groups. RESULTS: Seventy-four (35.6 %) of 208 patients underwent resection of the IPT. After adjustment for covariates, surgery was associated with improved OS (p = 0.04). Multivariable analysis revealed that estrogen receptor (ER) positivity (p = 0.002) and having only a single focus of metastatic disease (p = 0.05) were also associated with improved OS. Surgery was highly associated with receipt of RT (p = 0.0003). RT was significantly associated with improved survival (p = 0.015) in an exploratory analysis. CONCLUSIONS: Stage IV breast cancerpatients with an IPT treated surgically had significantly improved OS. Radiation to the primary was also associated with improved survival, but this was evident only with adjustment for the effect of surgery. These findings may be limited by selection bias. Completion of ongoing prospective randomized trials is needed to conclusively determine whether stage IV patients with an IPT should be offered aggressive locoregional therapy.
Authors: Gildy V Babiera; Roshni Rao; Lei Feng; Funda Meric-Bernstam; Henry M Kuerer; S Eva Singletary; Kelly K Hunt; Merrick I Ross; Karin M Gwyn; Barry W Feig; Frederick C Ames; Gabriel N Hortobagyi Journal: Ann Surg Oncol Date: 2006-04-17 Impact factor: 5.344
Authors: Yago Nieto; Samia Nawaz; Roy B Jones; Elizabeth J Shpall; Pablo J Cagnoni; Peter A McSweeney; Anna Barón; Carrington Razook; Steve Matthes; Scott I Bearman Journal: J Clin Oncol Date: 2002-02-01 Impact factor: 44.544
Authors: Hannah W Hazard; Seema R Gorla; Denise Scholtens; Krystyna Kiel; William J Gradishar; Seema A Khan Journal: Cancer Date: 2008-10-15 Impact factor: 6.860
Authors: Andrea C Bafford; Harold J Burstein; Christina R Barkley; Barbara L Smith; Stuart Lipsitz; James D Iglehart; Eric P Winer; Mehra Golshan Journal: Breast Cancer Res Treat Date: 2008-06-26 Impact factor: 4.872
Authors: Ryan C Fields; Donna B Jeffe; Kathryn Trinkaus; Qin Zhang; Carey Arthur; Rebecca Aft; Jill R Dietz; Timothy J Eberlein; William E Gillanders; Julie A Margenthaler Journal: Ann Surg Oncol Date: 2007-08-09 Impact factor: 5.344
Authors: Jennifer Gnerlich; Donna B Jeffe; Anjali D Deshpande; Courtney Beers; Christina Zander; Julie A Margenthaler Journal: Ann Surg Oncol Date: 2007-05-24 Impact factor: 5.344
Authors: Oleg Schmidt-Kittler; Thomas Ragg; Angela Daskalakis; Martin Granzow; Andre Ahr; Thomas J F Blankenstein; Manfred Kaufmann; Joachim Diebold; Hans Arnholdt; Peter Muller; Joachim Bischoff; Detlev Harich; Gunter Schlimok; Gert Riethmuller; Roland Eils; Christoph A Klein Journal: Proc Natl Acad Sci U S A Date: 2003-06-13 Impact factor: 11.205
Authors: Caitlin E Marks; Samantha M Thomas; Oluwadamilola M Fayanju; Gayle DiLalla; Sarah Sammons; E Shelley Hwang; Jennifer K Plichta Journal: Am J Surg Date: 2021-07-22 Impact factor: 2.565